Sequenom’s MassARRAY system is a DNA analysis platform that measures the amount of genetic target material and variations therein. MassARRAY delivers reliable and specific data […]
Despite the slowdown seen in the aesthetics market, second quarter revenue at Thermage totaled $17.9 million, a 2% increase over Q2 2007. International revenue increased […]
Cyberkinetics Neurotechnology, at one time an oft-discussed early stage device firm, has seen a steady decline in share price. Current market conditions are largely to […]
Not wanting to break a winning streak, Clarient delivered its 16th consecutive quarter of quarterly revenue growth. The company posted revenues of $16.9 million in […]
Chembio Diagnostics reported second quarter revenues of $2.72 million, an 8.6% increase over Q2 2007 and higher than any previous quarter. The lion’s share of […]
Some older news, in video form, care of our team at OneMedPlace TV. Thermage announced it would acquire Reliant Technologies earlier this month. The stock […]
The Radiology Group has developed a virtual, full-service radiology department with a complete range of specialty interpretations. The company aims to match the appropriate physician […]
Chembio Diagnostics develops, manufactures and markets rapid, point-of-care tests for the detection of HIV 1/ 2, Chagas and Sickle Cell disease as well as other […]
REPEL-CV, SyntheMed’s bioresorbable adhesion barrier film used following cardiac surgery, has received Health Canada approval for use in pediatric patients who undergo open heart procedures. […]
Timothy Sullivan, President and CEO of Mystic Pharmaceuticals, has been recognized by the editors of Medical Device & Diagnostic Industry as one of the magazine’s […]
Copyright © 2025 | WordPress Theme by MH Themes